Literature DB >> 25487410

The multifaceted aspects of refractory lupus nephritis.

Gabriella Moroni1, Claudio Ponticelli.   

Abstract

The term refractory lupus nephritis is generally used to indicate cases that do not respond to traditional treatment. However, the clinical presentation of lupus nephritis is variable and the time to response depends on the typology of the underlying renal syndrome. The criteria and the time for response are different in lupus patients with nephritic flares, in those with nephrotic syndrome, and in those with asymptomatic renal disease. In this paper, we will focus on the clinical characteristics, the consequences, and the possible therapeutic approaches for patients with different forms of refractory lupus nephritis, defined on the basis of renal syndrome at presentation.

Entities:  

Keywords:  lupus nephritis; nephritic flares; nephrotic syndrome; refractory nephritis; systemic lupus erythematosus

Mesh:

Year:  2014        PMID: 25487410     DOI: 10.1586/1744666X.2015.990883

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  4 in total

1.  Expert Perspective: An Approach to Refractory Lupus Nephritis.

Authors:  Swati Arora; Brad H Rovin
Journal:  Arthritis Rheumatol       Date:  2022-04-25       Impact factor: 15.483

2.  Immunosuppressive Treatment for Lupus Nephritis: Long-Term Results in 178 Patients.

Authors:  Elena V Zakharova; Tatiana A Makarova; Elena V Zvonova; Alina M Anilina; Ekaterina S Stolyarevich
Journal:  Biomed Res Int       Date:  2016-12-05       Impact factor: 3.411

3.  Outcome of participants with nephrotic syndrome in combined clinical trials of lupus nephritis.

Authors:  Liliana Michelle Gomez Mendez; Matthew D Cascino; Tamiko R Katsumoto; Paul Brakeman; Paul Brunetta; David Jayne; Maria Dall'Era; Brad Rovin; Jay Garg
Journal:  Lupus Sci Med       Date:  2019-02-04

4.  Effectiveness and safety of common therapeutic drugs for refractory lupus nephritis: A network meta-analysis.

Authors:  Jun Zhou; Meng-Jun Tao; Lai-Run Jin; Jun Sheng; Zhi Li; Hui Peng; Liang Xu; Hui Yuan
Journal:  Exp Ther Med       Date:  2019-11-29       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.